Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,000 | 2,230 | 14,420 | 17,950 | 11,250 |
| Depreciation Amortization | 810 | 400 | 2,450 | 1,540 | 1,090 |
| Other Working Capital | -260 | -1,170 | 1,760 | -1,050 | -3,850 |
| Other Operating Activity | 2,100 | 2,100 | 8,140 | 530 | 410 |
| Operating Cash Flow | $6,650 | $3,560 | $26,770 | $18,970 | $8,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,130 | -3,590 | -29,440 | -22,050 | -11,780 |
| Investing Cash Flow | $-7,130 | $-3,590 | $-29,440 | $-22,050 | $-11,780 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| Exchange Rate Effect | 20 | 8 | 60 | 20 | 6 |
| Beginning Cash Position | 1,340 | 1,340 | 3,940 | 3,940 | 3,940 |
| End Cash Position | 880 | 1,310 | 1,330 | 890 | 1,070 |
| Net Cash Flow | $-450 | $-20 | $-2,600 | $-3,040 | $-2,860 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,650 | 3,560 | 26,770 | 18,970 | 8,900 |
| Free Cash Flow | 6,650 | 3,560 | 26,770 | 18,970 | 8,900 |